Physician profile
Mai T Phan
NPI 1306879283
$2,050.88
in general payments reported to CMS, 2019-2025
20 companies · $170 in 2025
The $170 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $665 · 2020: $62.06 · 2021: $386 · 2022: $303 · 2023: $181 · 2024: $283 · 2025: $170.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $634.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $634.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $458.95 | 2019-2023 | |
| Janssen Pharmaceuticals, INC | $313.61 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $233.06 | 2019-2024 | Breztri, Lokelma |
| Regeneron Healthcare Solutions, INC. | $190.22 | 2024-2025 | Dupixent |
| Sun Pharmaceutical Industries INC. | $185.88 | 2021-2023 | Cequa |
| Covidien LP | $91.59 | 2019 | |
| Bausch & Lomb Americas INC. | $89.79 | 2024-2025 | Miebo, Xiidra |
| Pfizer INC. | $88.45 | 2019-2021 | |
| Abbvie INC. | $73.51 | 2023-2024 | |
| Exact Sciences Corporation | $58.11 | 2024-2025 | Cologuard Collection Kit |
| Hologic Sales and Service, LLC | $52.63 | 2021-2023 | Thinprep 2000 Processor, Aptima |
| Glaxosmithkline, LLC. | $39.46 | 2019-2022 | |
| Dompe US, INC. | $29.99 | 2022 | |
| Merck Sharp & Dohme LLC | $27.04 | 2021-2023 | Verquvo, Steglatro |
| Alcon Vision LLC | $23.50 | 2025 | Tryptyr |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $23.06 | 2021 | |
| Nabriva Therapeutics, Plc | $22.58 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $18.23 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $17.82 | 2025 | Zoryve |
| Amgen INC. | $13.40 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mai Phan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.